TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TechnoPhage SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11209
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ポルトガル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TechnoPhage SA (TechnoPhage) is a biopharmaceutical company that offers contract research and development of new molecules. The company conducts its research and development of new products based on unique properties of bacteriophages. It also conducts contract research and development services for private and public institutions and pharmaceutical companies, among others. TechnoPhage also collaborates with universities, national and international pharmaceutical companies, academic institutions, research centres and other industrial sectors. The company also operates its laboratories in the facilities of the Instituto de Medicina Molecular. TechoPhage is headquartered in Lisbon, Portugal.

TechnoPhage SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TechnoPhage SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TechnoPhage SA, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
TechnoPhage Enters into Agreement with Faculty of Veterinary Medicine, University of Lisbon 10
TechnoPhage Enters into Co-Development Agreement with University of Macau 11
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 12
TechnoPhage SA – Key Competitors 13
TechnoPhage SA – Key Employees 14
TechnoPhage SA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
TechnoPhage SA, Pharmaceuticals & Healthcare, Key Facts 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TechnoPhage SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TechnoPhage SA, Deals By Therapy Area, 2012 to YTD 2018 8
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TechnoPhage Enters into Agreement with Faculty of Veterinary Medicine, University of Lisbon 10
TechnoPhage Enters into Co-Development Agreement with University of Macau 11
TechnoPhage Enters into Co-Development Agreement with Shanghai Institute of Materia Medica 12
TechnoPhage SA, Key Competitors 13
TechnoPhage SA, Key Employees 14

List of Figures
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TechnoPhage SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TechnoPhage SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Johnson Matthey Plc (JMAT):製薬・医療:M&Aディール及び事業提携情報
    Summary Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fab …
  • SonaCare Medical LLC:医療機器:M&Aディール及び事業提携情報
    Summary SonaCare Medical LLC (SonaCare Medical), formerly US HIFU LLC is a medical device company that manufactures ultrasound surgical ablation systems. The company's products comprise sonablate 450 and sonatherm. It develops technologies for urological indications providing procedures that control …
  • Olea Medical SA:医療機器:M&Aディール及び事業提携情報
    Summary Olea Medical SA (Olea Medical), a subsidiary of Toshiba Medical Systems Corp, is a healthcare technology company that designs and markets medical imaging software products to healthcare industry. The company provides products such as advanced MR and CT perfusion imaging post-processing softw …
  • Dian Diagnostics Group Co Ltd (300244):製薬・医療:M&Aディール及び事業提携情報
    Summary Dian Diagnostics Group Co Ltd (Dian Diagnostics) is a medical diagnostic service provider. The company provides forensic authentication services, commercialization of diagnostic products, research and development in medical diagnostics and contract research services. It offers solutions in s …
  • First Quantum Minerals Ltd:企業のM&A・事業提携・投資動向
    First Quantum Minerals Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First Quantum Minerals Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • APL Co Pte Ltd:企業の戦略的SWOT分析
    APL Co Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Spotlight Innovation Inc (STLT):企業の財務・戦略的SWOT分析
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Rexahn Pharmaceuticals Inc (RNN):企業の財務・戦略的SWOT分析
    Summary Rexahn Pharmaceuticals Inc (Rexahn Pharmaceuticals), formerly Corporate Road Show.com Inc is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of cancer. The company develops anti-cancer drug candidates including Archexin that is intended for the tre …
  • BHP:企業の戦略・SWOT・財務情報
    BHP - Strategy, SWOT and Corporate Finance Report Summary BHP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing …
  • Beijing Shouhang IHW Resources Saving Technology Co Ltd (002665):電力:M&Aディール及び事業提携情報
    Summary Beijing Shouhang IHW Resources Saving Technology Co Ltd (Shouhang IHW Resources) is an electrical equipment company that offers heat generation systems. The company designs, manufactures and distributes CSP power generating system, thermal power plant air cooling system, waste heat power gen …
  • Lung Biotechnology PBC:医療機器:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …
  • Proserv:石油・ガス:M&Aディール及び事業提携情報
    Summary Proserv is an energy service provider that offers engineering services. The company offers drilling, surface, subsea and decommissioning services. Its subsea services comprise subsea engineering, subsea production equipment and services, subsea components and accessories, subsea production e …
  • Sekisui House Ltd (1928):企業の財務・戦略的SWOT分析
    Sekisui House Ltd (1928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Havila Shipping ASA (HAVI):石油・ガス:M&Aディール及び事業提携情報
    Summary Havila Shipping ASA (Havila) is a supplier of quality assured supply services to the international offshore industry. It owns and operates vessels and provides anchor handling, subsea construction, platform supply and multi-field rescue recovery services. The company’s fleet base includes an …
  • Torchmark Corp:企業の戦略・SWOT・財務情報
    Torchmark Corp - Strategy, SWOT and Corporate Finance Report Summary Torchmark Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Santander UK PLC:企業の戦略・SWOT・財務分析
    Santander UK PLC - Strategy, SWOT and Corporate Finance Report Summary Santander UK PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • RigNet Inc (RNET):企業の財務・戦略的SWOT分析
    RigNet Inc (RNET) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Prime Healthcare Services Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prime Healthcare Services Inc (Prime Healthcare) is a hospital management center that operates acute care hospitals. The center provides medical services such as emergency room, senior services, heart care services, behavioral health services, and others. It offers surgical services, wound h …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • La Jolla Pharmaceutical Company (LJPC):企業の財務・戦略的SWOT分析
    La Jolla Pharmaceutical Company (LJPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆